151 related articles for article (PubMed ID: 31732719)
1. DNA methylation-based classification reveals difference between pediatric T-cell acute lymphoblastic leukemia and normal thymocytes.
Kimura S; Seki M; Kawai T; Goto H; Yoshida K; Isobe T; Sekiguchi M; Watanabe K; Kubota Y; Nannya Y; Ueno H; Shiozawa Y; Suzuki H; Shiraishi Y; Ohki K; Kato M; Koh K; Kobayashi R; Deguchi T; Hashii Y; Imamura T; Sato A; Kiyokawa N; Manabe A; Sanada M; Mansour MR; Ohara A; Horibe K; Kobayashi M; Oka A; Hayashi Y; Miyano S; Hata K; Ogawa S; Takita J
Leukemia; 2020 Apr; 34(4):1163-1168. PubMed ID: 31732719
[No Abstract] [Full Text] [Related]
2. Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.
Balbach ST; Makarova O; Bonn BR; Zimmermann M; Rohde M; Oschlies I; Klapper W; Rössig C; Burkhardt B
Leukemia; 2016 Apr; 30(4):970-3. PubMed ID: 26216196
[No Abstract] [Full Text] [Related]
3. [Genetic and epigenetic landscape of pediatric T-cell acute lymphoblastic leukemia].
Kimura S
Rinsho Ketsueki; 2019; 60(5):459-467. PubMed ID: 31168014
[TBL] [Abstract][Full Text] [Related]
4. Deregulated FADD expression and phosphorylation in T-cell lymphoblastic lymphoma.
Marín-Rubio JL; de Arriba MC; Cobos-Fernández MA; González-Sánchez L; Ors I; Sastre I; Fernández-Piqueras J; Villa-Morales M
Oncotarget; 2016 Sep; 7(38):61485-61499. PubMed ID: 27556297
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation and copy number variation profiling of T-cell lymphoblastic leukemia and lymphoma.
Haider Z; Landfors M; Golovleva I; Erlanson M; Schmiegelow K; Flægstad T; Kanerva J; Norén-Nyström U; Hultdin M; Degerman S
Blood Cancer J; 2020 Apr; 10(4):45. PubMed ID: 32345961
[TBL] [Abstract][Full Text] [Related]
6. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
[TBL] [Abstract][Full Text] [Related]
7. DNA Methylation in T-Cell Acute Lymphoblastic Leukemia: In Search for Clinical and Biological Meaning.
Maćkowska N; Drobna-Śledzińska M; Witt M; Dawidowska M
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573325
[TBL] [Abstract][Full Text] [Related]
8. Calcium Signaling Is Impaired in PTEN-Deficient T Cell Acute Lymphoblastic Leukemia.
Pankaew S; Potier D; Grosjean C; Nozais M; Quessada J; Loosveld M; Remy É; Payet-Bornet D
Front Immunol; 2022; 13():797244. PubMed ID: 35185889
[TBL] [Abstract][Full Text] [Related]
9. Improved resolution of phenotypic subsets in human T-ALL by incorporation of RNA-seq based developmental profiling.
Wong R; Nguyen A; Wang X; Chong L; Tyshchenko K; Brown SD; Holt RA; Steidl C; Weng AP
Leuk Res; 2021 Nov; 110():106712. PubMed ID: 34583126
[No Abstract] [Full Text] [Related]
10. Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
Treanor LM; Zhou S; Janke L; Churchman ML; Ma Z; Lu T; Chen SC; Mullighan CG; Sorrentino BP
J Exp Med; 2014 Apr; 211(4):701-13. PubMed ID: 24687960
[TBL] [Abstract][Full Text] [Related]
11. Very long intergenic non-coding RNA transcripts and expression profiles are associated to specific childhood acute lymphoblastic leukemia subtypes.
Caron M; St-Onge P; Drouin S; Richer C; Sontag T; Busche S; Bourque G; Pastinen T; Sinnett D
PLoS One; 2018; 13(11):e0207250. PubMed ID: 30440012
[TBL] [Abstract][Full Text] [Related]
12. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols.
Taj MM; Moorman AV; Hamadeh L; Petit A; Asnafi V; Alby-Laurent F; Vora A; Mansour MR; Gale R; Chevret S; Moppett J; Baruchel A; Macintyre E
Leukemia; 2022 Jan; 36(1):263-266. PubMed ID: 34183766
[No Abstract] [Full Text] [Related]
14. Indolent T-lymphoblastic proliferation: a name with specific meaning.
Ohgami RS; Natkunam Y; Warnke RA
Hum Pathol; 2015 Nov; 46(11):1785-6. PubMed ID: 26363525
[No Abstract] [Full Text] [Related]
15. High PIM1 expression is a biomarker of T-cell acute lymphoblastic leukemia with JAK/STAT activation or t(6;7)(p21;q34)/TRB@-PIM1 rearrangement.
La Starza R; Messina M; Gianfelici V; Pierini V; Matteucci C; Pierini T; Limongi MZ; Vitale A; Roti G; Chiaretti S; Foà R; Mecucci C
Leukemia; 2018 Aug; 32(8):1807-1810. PubMed ID: 29479063
[No Abstract] [Full Text] [Related]
16. PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis.
Garcia EG; Veloso A; Oliveira ML; Allen JR; Loontiens S; Brunson D; Do D; Yan C; Morris R; Iyer S; Garcia SP; Iftimia N; Van Loocke W; Matthijssens F; McCarthy K; Barata JT; Speleman F; Taghon T; Gutierrez A; Van Vlierberghe P; Haas W; Blackburn JS; Langenau DM
Leukemia; 2021 Mar; 35(3):679-690. PubMed ID: 32606318
[TBL] [Abstract][Full Text] [Related]
17. Indolent T-lymphoblastic proliferation: a name with specific meaning--reply.
Nathwani BN; Kansal R; Yiakoumis X; Pangalis GA
Hum Pathol; 2015 Nov; 46(11):1786-7. PubMed ID: 26410056
[No Abstract] [Full Text] [Related]
18. Hematopoietic stem cell transplantation for adults with T-cell lymphoblastic lymphoma: can we successfully step into the era of precision medicine?
Young KH
Leukemia; 2020 Apr; 34(4):1213-1214. PubMed ID: 31641192
[No Abstract] [Full Text] [Related]
19. Clinical and biological relevance of genetic alterations in pediatric T-cell acute lymphoblastic leukemia in Taiwan.
Yeh TC; Liang DC; Liu HC; Jaing TH; Chen SH; Hou JY; Yang CP; Huang YJ; Yao HW; Huang TY; Lin TH; Shih LY
Pediatr Blood Cancer; 2019 Jan; 66(1):e27496. PubMed ID: 30280491
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL.
Touzart A; Lengliné E; Latiri M; Belhocine M; Smith C; Thomas X; Spicuglia S; Puthier D; Pflumio F; Leguay T; Graux C; Chalandon Y; Huguet F; Leprêtre S; Ifrah N; Dombret H; Macintyre E; Hunault M; Boissel N; Asnafi V
Clin Cancer Res; 2019 Apr; 25(8):2483-2493. PubMed ID: 30659025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
